PharmaShots | Incisive News in 3 Shots

Subscribe Now

Severe Hypoglycemia

PharmaShots Interview: Zealand Pharma's Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

PharmaShots Interview: Zealand Pharma's Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Ad...

September 27, 2021

Xeris' GVOKE (glucagon) Receives FDA's Approval as The First Ready-To-Use Stable Liquid Glucagon for Severe Hypoglycemia

Xeris' GVOKE (glucagon) Receives FDA's Approval as The First Ready-To-Use Stable Liquid Glucagon for Severe Hypoglycemia

September 11, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us